With industry expertise and Genomic Know-How, EA|Quintiles advances science from understanding the human genome and disease biology to detecting the effects of therapies and creating opportunities for those who can leverage new techniques and technologies. With over 500 collective years of genomic experience, 94 publications, FDA collaborations and participation in standardized initiatives, EA|Quintiles has upheld its market position as a leading provider of genomics services in clinical trials and research. Attend our webinar series to tap into our Genomic Know-How.
This program will benefit Discovery and Development Scientists from large pharmaceutical and small-midsize biotechnology companies.
To request the archives for this series contact Xtalks at (416) 977-6555 ext 371, or email firstname.lastname@example.org
Kim Robasky, PhD, Associate Director, Bioinformatics, EA
Dr. Robasky received her Ph.D. in bioinformatics from Boston University, with a research appointment in the Church Lab at the Department of Genetics at Harvard Medical School in 2013. Kimberly’s publications include analyses of whole genome and targeted sequencing data via phasing, haplotyping and variant interpretation with a focus on characterizing error to improve accuracy and clinical understanding. Kimberly is currently Associate Director of Bioinformatics for Expression Analysis, a Quintiles Company, in Durham, NC, where she has brought to bear her previous experience as a financial consulting software architect to institute and support best practices for software engineering and genomic data annotation. Kimberly’s current focus is on surveying existing datasets, including The Cancer Genome Atlas data, for clinically relevant features and cancer drug targets.Message Presenter
EA | Quintiles provides cutting-edge genomic sequencing, gene expression, genotyping, and bioinformatics services to pharmaceutical companies, diagnostic test developers, government agencies, and academic labs. EA | Quintiles conducts projects under clinical-grade quality control and offers bioinformatics expertise and computational infrastructure to process genomic data with consistency and speed.